Canadian Obesity Summit 2023

Michael Bidu, CEO of MYND Therapeutics, presented at the Canadian Obesity Summit 2023 held in Whistler, British Columbia. The summit brought together leading researchers, clinicians, and innovators in the field of obesity care.

Bidu's presentation focused on the intersection of digital health and immersive technologies — specifically how VR and AR-delivered cognitive behavioral therapy can transform obesity treatment. He highlighted the growing role of consumers in driving change within the healthcare system, emphasizing that patient engagement and empowerment are key to long-term success.

The talk explored how MYNDSET, MYND Therapeutics' flagship digital therapeutic platform, leverages gamification and immersive experiences to improve adherence and outcomes for patients managing obesity. Bidu shared early results from pilot studies demonstrating high usability satisfaction and meaningful weight loss among participants.

The Canadian Obesity Summit is Canada's premier scientific conference on obesity, attracting hundreds of healthcare professionals and researchers annually. MYND Therapeutics' participation underscores the company's commitment to advancing evidence-based digital solutions for chronic disease management.